Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species

Journal of Neurochemistry

Volumn 69, Issue 3, 1997, Pages 1185-1195

  Berman, Sarah B ^a   Hastings, Teresa G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Excitotoxicity; Free radicals; Glutamate uptake; Ischemia; Methamphetamine; Oxidative stress

Indexed keywords

GLUTAMIC ACID; METHAMPHETAMINE; REACTIVE OXYGEN METABOLITE;

AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; DRUG INHIBITION; NERVE DEGENERATION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; SYNAPTOSOME; TRANSPORT KINETICS;

ANIMALIA;

EID: 0030857351     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69031185.x     Document Type: Article

References (79)

1. Abekawa T., Ohmori T., and Koyama T. (1988) Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res. 643, 276-281.
2. Arriza J. L., Fairman W. A., Wadiche J. I., Murdoch G. H., Kavanaugh M. P., and Amara S. G. (1994) Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14, 5559-5569.
3. Berman S. B., Zigmond M. J., and Hastings T. G. (1996) Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J. Neurochem. 67, 593-600.
4. Bouvier M., Szatkowski M., Amato A., and Attwell D. (1992) The glial cell glutamate uptake carrier countertransports pH-changing anions. Nature 360, 471-474.
5. Bradford M. A. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
6. Braughler J. M. and Hall E. D. (1989) Central nervous system trauma and stroke: I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic. Biol. Med. 6, 289-301.
7. Brown R. H. (1995) Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80, 687-692.
8. Buisson A., Callebert J., Mathieu E., Plotkine M., and Boulu R. G. (1992) Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia. J. Neurochem. 59, 1153-1157.
9. Cadet J. L., Sheng P., Ali S., Rothman R., Carlson E., and Epstein C. (1994) Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62, 380-383.
10. Chapman A. G., Dürmuller N., Lees G. J., and Meldrum B. S. (1989) Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres. Neurosci. Lett. 107, 256-260.
11. Choi D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
12. Choi D. W. and Rothman J. (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13, 171-182.
13. Coyle J. T. and Puttfarcken P. (1993) Oxidative stress, glutamate and neurodegenerative disorders. Science 262, 689-695.
14. Cubells J. F., Rayport S., Rajendran G., and Sulzer D. (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14, 2260-2271.
15. Davies K. J. A., Delsignore M. E., and Lin S.W. (1987) Protein damage and degradation by oxygen radicals: II. Modification of amino acids. J. Biol. Chem. 262, 9902-9907.
16. DeVito M. J. and Wagner G. C. (1989) Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 28, 1145-1150.
17. Dugan L. L., Sensi S. L., Canzoniero L. M., Handran S. D., Rothman S. M., Lin T. S., Goldberg M. P., and Choi D. W. (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15, 6377-6388.
18. Farfel G. M., Vosmer G. L., and Seiden L. S. (1992) The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 2,4-methylenedioxy-methamphetamine, and p-chloroamphetamine. Brain Res. 595, 121-127.
19. Filloux F. and Wamsley J. K. (1991) Dopaminergic modulation of excitotoxicity in rat striatum: evidence from nigrostriatal lesions. Synapse 8, 281-288.
20. Finnegan K. T. and Taraska T. (1996) Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine-induced striatal dopamine release in vivo. J. Neurochem. 66, 1949-1958.
21. Fornstedt B., Bergh I., Rosengren E., and Carlsson A. (1990) An improved HPLC-electrochemical detection method for measur-ing brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid. J. Neurochem. 54, 578-586.
22. Garris P. A., Ciolkowski E. L., Pastore P., and Wightman R. M. (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J. Neurosci. 14, 6084-6093.
23. Giovanni A., Liang L. P., Hastings T. G., and Zigmond M. J. (1995) Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64, 1819-1825.
24. Giros B., El Mestikawy S., Bertrand L., and Caron M. G. (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295, 149-154.
25. Globus M. Y.-T., Ginsberg M. D., Dietrich W. D., Busto R., and Scheinberg P. (1987) Substantia nigra lesion protects against ischemic damage in the striatum. Neurosci. Lett. 80, 251-256.
26. Globus M. Y.-T., Busto R., Dietrich W. D., Martinez E., Valdes I., and Ginsberg M. D. (1988) Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and γ-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51, 1455-1464.
27. Graham D. G. (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14, 633-643.
28. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
29. Hastings T. G. (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J. Neurochem. 64, 919-924.
30. 3H]-dopamine: impact of ascorbic acid and glutathione. J. Neurochem. 63, 1126-1132.
31. Hastings T. G., Lewis D., and Zigmond M. J. (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA 93, 1956-1961.
32. Hediger M. A., Kanai Y., You G., and Nussberger S. (1995) Mammalian ion-coupled solute transporters. J. Physiol. (Lond.) 482.P, 7S-17S.
33. Henn F. A., Anderson D. J., and Rustad D. G. (1976) Glial contamination of synaptosomal fractions. Brain Res. 101, 341-344.
34. Kanai Y. and Hediger M. A. (1992) Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360, 467-471.
35. Kerkerian L., Dusticier N., and Nieoullon A. (1987) Modulatory effect of dopamine on high-affinity glutamate uptake in the rat striatum. J. Neurochem. 48, 1301-1306.
36. Kilty J. E., Lorang D., and Amara S. G. (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254, 578-579.
37. Korytowski W., Sarna T., Kalyanaraman B., and Sealy R. C. (1987) Tyrosinase-catalyzed oxidation of dopa and related catechol(amine)s: a kinetic electron spin resonance investigation using spin-stabilization and spin label oximetry. Biochim. Biophys. Acta 924, 383-392.
38. Lafon-Cazal M., Pietri S., Culcasi M., and Bockaert J. (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-537.
39. 3H] glutamate by striatal synaptosomes. J. Neurochem. 63, 2108-2117.
40. Maker H. S., Weiss C., Silides D. J., and Cohen G. (1981) Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates. J. Neurochem. 36, 589-593.
41. Massieu L., Morales-Villagrán A., and Tapia R. (1995) Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. J. Neurochem. 64, 2262-2272.
42. McBean G. J. and Roberts P. J. (1985) Neurotoxicity of L-glutamate and DL-threo-3-hydroxyaspartate in the rat striatum. J. Neurochem. 44, 247-254.
43. McCord J. M. and Fridovich I. (1969) Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244, 6049-6055.
44. Miyamoto M., Murphy T. H., Schnaar R. L., and Coyle J. T. (1989) Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J. Pharmacol. Exp. Ther. 250, 1132-1140.
45. Monyer H., Hartley D. M., and Choi D. W. (1990) 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures. Neuron 5, 121-126.
46. 2+ release by rat liver mitochondria. Arch. Biochem. Biophys. 267, 539-550.
47. Murphy T. H., Miyamoto M., Sastre A., Schnaar R. L., and Coyle J. T. (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2, 1547-1558.
48. Nieoullon A., Kerkerian L., and Dusticier N. (1982) Inhibitory effects of dopamine on high affinity glutamate uptake from rat striatum. Life Sci. 30, 1165-1172.
49. Petronelli V., Costantini P., Scorrano L., Colonna R., Passamonti S., and Bernardi P. (1994) The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols: increase of the gating potential by oxidants and its reversal by reducing agents. J. Biol. Chem. 269, 16638-16642.
50. Pines G., Danbolt N. C., Bjørås M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., and Kanner B. I. (1992) Cloning and expression of a rat brain L-glutamate transporter. Nature 360, 464-467.
51. 3H-glutamate transport in synaptosomes. Synapse 18, 21-26.
52. Radi R., Beckman J. S., Bush K. M., and Freeman B. A. (1991) Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 206, 4244-4250.
53. Reynolds I. J. and Hastings T. G. (1995) Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 15, 3318-3327.
54. Roettger V. and Lipton P. (1996) Mechanism of glutamate release from rat hippocampal slices during in vitro ischemia. Neuroscience 75, 677-685.
55. Rothstein J. D., Martin L. J., and Kuncl R. W. (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 32, 1464-1468.
56. Rothstein J. D., Jin L., Dykes-Hoberg M., and Kuncl R. W. (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA 90, 6591-6595.
57. Rothstein J. D., Van Kammen M., Levey A. I., Martin L. J., and Kuncl R. W. (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73-84.
58. Rothstein J. D., Dykes-Hoberg M., Pardo C. A., Bristol L. A., Jin L., Kuncl R. W., Kanai Y., Hediger M. A., Wang Y., Schielke J. P., and Welty D. F. (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686.
59. Schmidt C. J., Ritter J. K., Sonsalla P. K., Hanson G. R., and Gibb J. W. (1985) Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233, 539-544.
60. Schulz J. B., Henshaw D. R., Siwek D., Jenkins B. G., Ferrante R. J., Cipolloni P. B., Kowall N. W., Rosen B. R., and Beal M. F. (1995) Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 64, 2239-2247.
61. Shafqat S., Velaz-Faircloth M., Guadano-Ferraz A., and Fremeau R. T. (1993) Molecular characterization of neurotransmitter transporters. Mol. Endocrinol. 7, 1517-1529.
62. Shimada S., Kitayama S., Lin C.-L., Patel A., Nanthakumar E., Gregor P., Kuhar M., and Uhl G. (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576-578.
63. 3H] dopamine uptake in rat striatum during aging. J. Neurochem. 56, 575-579.
64. Sonsalla P. K., Riordan D. E., and Heikkila R. E. (1991) Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J. Pharmacol. Exp. Ther. 256, 506-512.
65. Stadtman E. R. (1991) Ascorbic acid and oxidative inactivation of proteins. Am. J. Clin. Nutr. 54, 1125S-1128S.
66. Stephans S. E. and Yamamoto B. K. (1994) Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 17, 203-209.
67. +-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. USA 89, 10955-10959.
68. +)-stimulated ATPase in brain: separation, and difference in affinity for strophanthidin. J. Biol. Chem. 254, 6060-6067.
69. + concentrations. J. Neurochem. 66, 2057-2066.
70. Trotti D., Rossi D., Gjesdal O., Levy L. M., Racagni G., Danbolt N. C., and Volterra A. (1996) Peroxynitrite inhibits glutamate transporter subtypes. J. Biol. Chem. 271, 5976-5979.
71. Tse D. C. S., McCreery R. L., and Adams R. N. (1976) Potential oxidative pathways of brain catecholamines. J. Med. Chem. 19, 37-40.
72. Velasco I., Tapia R., and Massieu L. (1996) Inhibition of glutamate uptake induces progressive accumulation of extracellular glutamate and neuronal damage in rat cortical cultures. J. Neurosci. Res. 44, 551-561.
73. Volterra A., Trotti D., Tromba C., Floridi S., and Racagni G. (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14, 2924-2932.
74. Weinberger J., Nieves-Rosa J., and Cohen G. (1985) Nerve terminal damage in cerebral ischemia: protective effect of alpha-methylpara-tyrosine. Stroke 16, 864-870.
75. Wheeler D. D., Edwards A. M., and Ondo J. G. (1993) Dopamine uptake in five structures of the brain: comparison of rate, sodium dependence and sensitivity to cocaine. Neuropharmacology 32, 501-508.
76. Wroblewski F. and LaDue J. S. (1955) Lactic acid dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med. 90, 210-215.
77. 3H] dopamine. Neuropharmacology 29, 475-486.
78. Zhang Y., Marcillat O., Giulivi C., Ernster L., and Davies K. J. A. (1990) The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265, 16330-16336.
79. Zigmond M. J., Hastings T. G., and Abercrombie E. D. (1992) Neurochemical responses to 6-hydroxydopamine and L-dopa therapy: implications for Parkinson's disease. Ann. NY Acad. Sci. 648, 71-86.